| Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the Democratic Republic of Congo AW Rimoin, PM Mulembakani, SC Johnston, JO Lloyd Smith, NK Kisalu, ... Proceedings of the National Academy of Sciences 107 (37), 16262-16267, 2010 | 813 | 2010 |
| Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody D Corti, J Misasi, S Mulangu, DA Stanley, M Kanekiyo, S Wollen, ... Science 351 (6279), 1339-1342, 2016 | 411 | 2016 |
| Genomic variability of monkeypox virus among humans, Democratic Republic of the Congo JR Kugelman, SC Johnston, PM Mulembakani, N Kisalu, MS Lee, ... Emerging infectious diseases 20 (2), 232, 2014 | 319 | 2014 |
| A human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasite NK Kisalu, AH Idris, C Weidle, Y Flores-Garcia, BJ Flynn, BK Sack, ... Nature medicine 24 (4), 408-416, 2018 | 261 | 2018 |
| Endemic human monkeypox, democratic Republic of Congo, 2001–2004 AW Rimoin, N Kisalu, B Kebela-Ilunga, T Mukaba, LL Wright, P Formenty, ... Emerging infectious diseases 13 (6), 934, 2007 | 189 | 2007 |
| A monoclonal antibody for malaria prevention MR Gaudinski, NM Berkowitz, AH Idris, EE Coates, LSA Holman, ... New England Journal of Medicine 385 (9), 803-814, 2021 | 137 | 2021 |
| A potent anti-malarial human monoclonal antibody targets circumsporozoite protein minor repeats and neutralizes sporozoites in the liver LT Wang, LS Pereira, Y Flores-Garcia, J O’Connor, BJ Flynn, A Schön, ... Immunity 53 (4), 733-744. e8, 2020 | 118 | 2020 |
| Propulsion of African trypanosomes is driven by bihelical waves with alternating chirality separated by kinks JA Rodríguez, MA Lopez, MC Thayer, Y Zhao, M Oberholzer, DD Chang, ... Proceedings of the National Academy of Sciences 106 (46), 19322-19327, 2009 | 90 | 2009 |
| Using remote sensing to map the risk of human monkeypox virus in the Congo Basin T Fuller, HA Thomassen, PM Mulembakani, SC Johnston, JO Lloyd-Smith, ... EcoHealth 8, 14-25, 2011 | 89 | 2011 |
| Low-dose subcutaneous or intravenous monoclonal antibody to prevent malaria RL Wu, AH Idris, NM Berkowitz, M Happe, MR Gaudinski, C Buettner, ... New England Journal of Medicine 387 (5), 397-407, 2022 | 82 | 2022 |
| Cytokine modulation correlates with severity of monkeypox disease in humans SC Johnston, JC Johnson, SW Stonier, KL Lin, NK Kisalu, LE Hensley, ... Journal of Clinical Virology 63, 42-45, 2015 | 74 | 2015 |
| Varicella coinfection in patients with active monkeypox in the Democratic Republic of the Congo NA Hoff, DS Morier, NK Kisalu, SC Johnston, RH Doshi, LE Hensley, ... Ecohealth 14, 564-574, 2017 | 60 | 2017 |
| Safety and efficacy of a monoclonal antibody against malaria in Mali K Kayentao, A Ongoiba, AC Preston, SA Healy, S Doumbo, D Doumtabe, ... New England Journal of Medicine 387 (20), 1833-1842, 2022 | 59 | 2022 |
| Toward understanding the outcomes of monkeypox infection in human pregnancy NK Kisalu, JL Mokili The Journal of infectious diseases 216 (7), 795-797, 2017 | 54 | 2017 |
| Pathogen-host associations and predicted range shifts of human monkeypox in response to climate change in central Africa HA Thomassen, T Fuller, S Asefi-Najafabady, JAG Shiplacoff, ... PLoS One 8 (7), e66071, 2013 | 51 | 2013 |
| Serologic evidence of ebolavirus infection in a population with no history of outbreaks in the Democratic Republic of the Congo S Mulangu, VH Alfonso, NA Hoff, RH Doshi, P Mulembakani, NK Kisalu, ... The Journal of Infectious Diseases 217 (4), 529-537, 2018 | 49 | 2018 |
| Parasite motility is critical for virulence of African trypanosomes MM Shimogawa, SS Ray, N Kisalu, Y Zhang, Q Geng, A Ozcan, KL Hill Scientific Reports 8 (1), 9122, 2018 | 48 | 2018 |
| Structure-function analysis of dynein light chain 1 identifies viable motility mutants in bloodstream-form Trypanosoma brucei KS Ralston, NK Kisalu, KL Hill Eukaryotic Cell 10 (7), 884-894, 2011 | 39 | 2011 |
| Enhancing durability of CIS43 monoclonal antibody by Fc mutation or AAV delivery for malaria prevention NK Kisalu, LD Pereira, K Ernste, Y Flores-Garcia, AH Idris, M Asokan, ... JCI insight 6 (3), 2021 | 33 | 2021 |
| The P. falciparum CSP repeat region contains three distinct epitopes required for protection by antibodies in vivo Y Flores-Garcia, LT Wang, M Park, B Asady, AH Idris, NK Kisalu, C Muñoz, ... PLoS pathogens 17 (11), e1010042, 2021 | 28 | 2021 |
